Bio-Techne (TECH) stock saw a quick boost as investors responded to reports that the Trump administration is considering a two-year extension of Affordable Care Act subsidies. This development is ...
We came across a bullish thesis on Bio-Techne Corporation on Valueinvestorsclub.com by rab. In this article, we will summarize the bulls’ thesis on TECH. Bio-Techne Corporation's share was trading at ...
Nobel prize for medicine laureate Katalin Kariko addresses a press conference at the Hungarian Academy of Sciences in Budapest on October 11, 2023. Earlier this month, Katalin Kariko and Drew Weissman ...
Bio-Techne outlines 2025 growth drivers with NIH uncertainty and strong Protein Sciences performance
Management expects growth momentum to slow to low-single digits in Q4 due to uncertainties around NIH funding and tariffs. Adjusted operating margin is projected to be 100 to 150 basis points lower in ...
Management reaffirmed organic revenue growth guidance of mid-single digits for Q3 and high single digits by Q4. Improvement is expected in China, driven by stimulus programs and increased government ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback